Publication | Closed Access

Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography

Positron Emission TomographyNeurodegenerative DiseasesAlzheimer's DiseaseMedicineNeurochemical BiomarkersNeurologyNeuroscienceNeurodegenerationMild Cognitive ImpairmentBrain PathologyAlzheimer ’Geriatric Neurology